Iris Grossman
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
-
- Multiple Sclerosis Research Studies 12
- Co-authors
- Michael R. Hayden (15 shared papers)Deborah Fass (6 shared papers)David B. Goldstein (7 shared papers)Assaf Alon (3 shared papers)Tal Ilani (3 shared papers)Rebecca L. Kusko (6 shared papers)Michal Geva (5 shared papers)Elena Kartvelishvily (1 shared paper)
- Journals
- Alzheimer s & Dementia (3 papers)Neurology (3 papers)The EPMA Journal (2 papers)Scientific Reports (2 papers)Genetics in Medicine (2 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Iris Grossman
49 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Pharmacology 239
- Biological Psychiatry 15
- Pathology and Forensic Medicine 179
- Cellular and Molecular Neuroscience 157
- Psychiatry and Mental health 158
Countries citing papers authored by Iris Grossman
This map shows the geographic impact of Iris Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Grossman more than expected).
Fields of papers citing papers by Iris Grossman
This network shows the impact of papers produced by Iris Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Grossman. The network helps show where Iris Grossman may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Grossman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 145 | |
| 2 | 2016 | 122 | |
| 3 | 2016 | 116 | |
| 4 | 2009 | 86 | |
| 5 | 2016 | 72 | |
| 6 | 2012 | 69 | |
| 7 | 2007 | 61 | |
| 8 | 2013 | 57 | |
| 9 | Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs). | 2007 | 55 |
| 10 | 2007 | 55 | |
| 11 | 2016 | 54 | |
| 12 | 2012 | 50 | |
| 13 | 2008 | 48 | |
| 14 | 2017 | 40 | |
| 15 | 2018 | 37 | |
| 16 | 2007 | 36 | |
| 17 | 2008 | 35 | |
| 18 | 2010 | 34 | |
| 19 | 2020 | 34 | |
| 20 | 2004 | 31 |
About Iris Grossman
Iris Grossman is a scholar working on Pharmacology, Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Immunology, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Multiple Sclerosis Research Studies (12 papers), Genetic Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Genetic Associations and Epidemiology (4 papers) and Redox biology and oxidative stress (4 papers). The work is most often cited by research in Pharmacology (239 citations), Biological Psychiatry (15 citations), Pathology and Forensic Medicine (179 citations), Cellular and Molecular Neuroscience (157 citations) and Psychiatry and Mental health (158 citations). Iris Grossman has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Michael R. Hayden, Deborah Fass, David B. Goldstein, Assaf Alon, Tal Ilani, Rebecca L. Kusko, Michal Geva, Elena Kartvelishvily, Sidney Cohen and Donna G. Crenshaw. Their work appears in journals such as Alzheimer s & Dementia, Neurology, The EPMA Journal, Scientific Reports and Genetics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.